running

Full-time Faculty

Ling-Wei Hsin

Field of study:Drug discovery and development; Medicinal chemistry; Organic synthesis; Pharmaceutical analysis; New radiopharmaceutics
Telephone:(02)3366-8696
E-mail:lwhsin@ntu.edu.tw
My job:Associate Professor / Director, Center for Innovative Therapeutics Discovery
Personal website:https://scholars.lib.ntu.edu.tw/cris/rp/rp06623

Education : Ph.D.- Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University 1990-1995
B.S.- School of Pharmacy, National Taiwan University 1986-1990
Experience : 2002~ Assistant Professor(School of Pharmacy, College of Medicine, National Taiwan University)

2001-2002 Instructor(School of Pharmacy, College of Medicine, National Taiwan University)

1997-2000 Fogarty Fellow
Sponsor: Dr. Kenner C. Rice; Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Maryland, USA
Design, synthesis, and structure-activity relationships of non-peptide corticotropin-releasing hormone receptor antagonists.
The development of chiral derivatives of GBR 12909 and GBR 12935 as potential cocaine abuse therapeutic agents.
Synthesis of radiopharmaceuticals as potential PET and SPECT imaging agents.

1995-1997 Pharmaceutical Analysis Scientist
The Analytical Center of Medical Supplies
National Defense Medical Center Taipei, Taiwan
Quantitative and qualitative analyses of prescription drugs and other medical supplies.
The development of antidotes for the treatment of neurotoxic agent intoxication.
Synthesis of opioid receptor antagonists for pharmacological studies.
Research Areas : Drug discovery and development; Medicinal chemistry; Organic synthesis; Pharmaceutical analysis; New radiopharmaceutics
Lab Focus : 1. Discovery of early diagnostic agents and personalized precision medicine for Alzheimer's disease
2. New drug development for Irritable Bowel Syndrome
3. Design, synthesis, and application in translational medicine of new drugs for neurodegenerative disease and neuropsychiatric disorders

One-pot tandem reduction and site-selective halogenation of nitroarenes
(2023-12-21) Dhandabani, Ganesh Kumar ; Chang, Li-Te ; Hsieh, Hao-Yu ; Shih, Chia-Ling ; LING-WEI HSIN

Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities
(2023-12) Chu, Jung-Chun ; Tseng, Hui-Ju ; Lee, Sung-Bau ; Hsu, Kai-Cheng ; LING-WEI HSIN ; Liang, Ru-Hao ; Lin, Tony Eight ; Gao, Nain-Chu ; Chen, Liang-Chieh ; Lu, Wan-Hsun ; Wang, Andrew H-J ; Huang, Wei-Jan

5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome
(2022-09-18) Chang, Wen-Ying ; Yang, Yi-Ting ; She, Meng-Ping ; CHIA-HUNG TU ; Lee, Tsung-Chun ; Wu, Ming-Shiang ; CHIN-HUNG SUN ; LING-WEI HSIN ; LINDA CHIA-HUI YU

Synthesis and biological evaluation of phenothiazine derivative-containing hydroxamic acids as potent class II histone deacetylase inhibitors
(2021) Hsu K.-C. ; Chu J.-C. ; Tseng H.-J. ; Liu C.-I. ; Wang H.-C. ; Lin T.E. ; Lee H.-S. ; LING-WEI HSIN ; Wang A.H.-J. ; Lin C.-H. ; Huang W.-J.

Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use
(2020) Shih, Kai-Ting ; Huang, Ya-Yao ; Yang, Chia-Ying ; MEI-FANG CHENG ; YU-WEN TIEN ; Shiue, Chyng-Yann ; RUOH-FANG YEN ; LING-WEI HSIN

more

Exploration of 18f-Labeled N-Substituted Pyridoindoles and Pyrrolodipyridines as Molecular Probes with Phosphorylated Tau Protein-Specificity and Potential for Precise Diagnosis of Neurodegenerative Diseases
(2023-08-01~) LING-WEI HSIN

Impurities Analysis of Drugs and Structure Characterization and Composition Analysis of Herbal Medicines and Metabolites( III )
(2023-02-01~) PI-HUI LIANG

腸躁症新藥開發: 非GLP臨床前試驗(II)
(2022-11-01~) LING-WEI HSIN

Exploration of 18f-Labeled N-Substituted Pyridoindoles and Pyrrolodipyridines as Molecular Probes with Phosphorylated Tau Protein-Specificity and Potential for Precise Diagnosis of Neurodegenerative Diseases
(2022-08-01~) LING-WEI HSIN

Impurities Analysis of Drugs and Structure Characterization and Composition Analysis of Herbal Medicines and Metabolites( II )
(2022-02-01~) PI-HUI LIANG

more